|4Dec 13, 4:06 PM ET

Krasnow Lineene Norris 4

4 · Medidata Solutions, Inc. · Filed Dec 13, 2012

Insider Transaction Report

Form 4
Period: 2012-12-11
Krasnow Lineene Norris
EVP - Product and Marketing
Transactions
  • Exercise/Conversion

    Common Stock

    2012-12-11$15.70/sh+3,151$49,47160,517 total
  • Exercise/Conversion

    Common Stock

    2012-12-12$15.70/sh+5,531$86,83762,897 total
  • Sale

    Common Stock

    2012-12-11$38.42/sh3,151$121,06857,366 total
  • Exercise/Conversion

    Stock Option (Right to buy)

    2012-12-113,15169,349 total
    Exercise: $15.70Exp: 2019-01-15Common Stock (3,151 underlying)
  • Sale

    Common Stock

    2012-12-12$38.56/sh5,531$213,27057,366 total
  • Exercise/Conversion

    Stock Option (Right to buy)

    2012-12-125,53163,818 total
    Exercise: $15.70Exp: 2019-01-15Common Stock (5,531 underlying)
Footnotes (3)
  • [F1]Such transaction was executed in multiple trades at prices ranging from $38.40 to $38.45. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Such transaction was executed in multiple trades at prices ranging from $38.50 to $38.611. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]These options vest in 48 equal monthly installments commencing one month after the grant date, subject to continued employment.

Documents

1 file
  • 4
    rrd363477.xmlPrimary

    FORM 4 - LINEENE KRASNOW - EXERCISE AND SALE